We are excited to announce our newest product launch for 2021. The new product is a metabolite, derived from Trichoderma, and has consistently provided increased yields in numerous field trials. This novel product is our first non-living biological seed treatment. It will also be available as an in-furrow application. This new product launch has been in the works since 2014 and focuses on extensive research from our R&D facility in Geneva, NY. It is a result of our extensive work with Trichoderma.
The new product featured provides superior field performance, excellent root stimulation, and drought tolerance. These benefits provide yield increases of up to 11 bushels per acre. The product is expected to be available in early 2021.